FCM
CLVS
Farallon Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-600,000
| Closed | -$14.9M | – | 108 |
|
|
2019
Q1 | $14.9M | Sell |
600,000
-400,000
| -40% | -$9.93M | 0.11% | 76 |
|
|
2018
Q4 | $18M | Buy |
+1,000,000
| New | +$18M | 0.13% | 67 |
|
|
2017
Q3 | – | Sell |
-610,000
| Closed | -$57.1M | – | 94 |
|
|
2017
Q2 | $57.1M | Buy |
610,000
+530,000
| +663% | +$49.6M | 0.59% | 34 |
|
|
2017
Q1 | $5.09M | Buy |
+80,000
| New | +$5.09M | 0.06% | 63 |
|
|
2014
Q4 | – | Sell |
-225,000
| Closed | -$10.2M | – | 97 |
|
|
2014
Q3 | $10.2M | Hold |
225,000
| – | – | 0.16% | 62 |
|
|
2014
Q2 | $9.32M | Buy |
+225,000
| New | +$9.32M | 0.13% | 67 |
|